VALENTI, LUCA VITTORIO CARLO

VALENTI, LUCA VITTORIO CARLO  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 456 (tempo di esecuzione: 0.008 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 1-mar-2016 L. ValentiS. Fargion + Article (author) -
A 360-degree overview of paediatric NAFLD: Recent insights 1-giu-2013 L. Valenti + Article (author) -
A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease 1-gen-2014 B. DonatiL. Valenti + Article (author) -
A call to action for fatty liver disease 1-giu-2021 Valenti L. + Article (author) -
A drug transporter gene polymorphism predicts renal tubular toxicity in patients with chronic hepatitis B on long-term adefovir and lamivudine combination 1-apr-2010 P. LamperticoP. DongiovanniL. V. C. ValentiS. R. FargionM. Colombo + Article (author) -
A genetic hypothesis for burnt-out steatohepatitis 21-dic-2021 Valenti L. + Article (author) -
A new definition for metabolic dysfunction-associated fatty liver disease : an international expert consensus statement 1-lug-2020 Valenti L. + Article (author) -
A novel alpha1-antitrypsin null variant (PiQ0Milano) 27-ago-2013 R. RamettaP. DongiovanniM. FaralloS. FargionL. Valenti + Article (author) -
A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease 16-lug-2017 Dongiovanni, PaolaValenti, Luca Article (author) -
A pdcd1 role in the genetic predisposition to nafld-hcc? 19-mar-2021 Valenti L. + Article (author) -
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 1-gen-2021 Valenti L. + Article (author) -
A population-based study on the prevalence of NASH using scores validated against liver histology 1-apr-2014 L. ValentiS. Fargion + Article (author) -
A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosis 1-nov-2010 L. ValentiA.L. FracanzaniP. DongiovanniS. Fargion + Article (author) -
A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia 21-mar-2014 L. ValentiA.L. FracanzaniP. DongiovanniS. RovidaR. RamettaE. FattaE.A. PulixiS. Fargion + Article (author) -
A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype 1-set-2011 E. GalmozziR. RamettaP. DongiovanniA. L. FracanzaniS. R. FargionL. V. C. Valenti + Article (author) -
A1-antitripsin mutations are associated with altered iron metabolism but not liver damage in non alcoholic fatty liver disease 4-lug-2007 L. ValentiP. DongiovanniA.L FracanzaniS. Fargion + Book Part (author) -
Aberrant methylation of oncosuppressor genes detected in the peripheral blood of patients with chronic hepatitis C and hepatocellular carcinoma 1-mar-2011 M. SampietroA.L. FracanzaniD. TavazziC. BertelliD. BignaminiL.V.C. ValentiS.R. Fargion + Article (author) -
Accuracy of imaging methods for steatohepatitis diagnosis in non-alcoholic fatty liver disease patients: A systematic review 1-gen-2019 Valenti L. + Article (author) -
Acquired hepatocerebral degeneration (AHD) : a peculiar neurological impairment in advanced chronic liver disease 1-feb-2018 A. PigoniF. IuculanoC. SaettiS. SpreaficoM. CurioniR. LombardiL. ValentiA..L. FracanzaniS. Fargion + Article (author) -
Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver 23-mar-2021 Rametta R.Dongiovanni P.Valenti L. + Article (author) -